Takeda’s new net-zero emissions targets for 2035 and 2040

At Takeda we are accelerating our target to achieve net-zero^[1] before 2035 for greenhouse gas (GHG) emissions generated both directly and indirectly (scopes 1 and 2). For emissions generated through the purchase, use and disposal of our products (estimated scope 3), we are committing to achieve net-zero before 2040.

To understand the significance of being net-zero and these new targets, it’s helpful to know what we’ve already done.

Since 2020, Takeda has been carbon neutral, which means we’ve minimized fossil fuel reliance and invested in projects that prevent emissions – such as renewable energy or forest protection projects – to compensate for the remaining emissions.

“Net-zero” goes much further than that. It means eliminating at least 90% of carbon emissions and then taking the additional step of removing the residual emissions by investing in direct carbon capture projects or growing entirely new forests.

Our new targets enable us to remove carbon earlier, put us on a path to protect the planet, and make our climate stance the most aggressive among our peers.

“And importantly,” says Takako Ohyabu, Chief Global Corporate Affairs and Sustainability Officer, “it furthers our purpose-led sustainability journey – how we meet patients’ needs over the long-term while creating greater societal value by growing our business.”

[1] Takeda defines “net-zero” in accordance with the Science Based Targets initiative Corporate Net-Zero Standard and follows the GHG Protocol for carbon neutrality.

Forward-Looking Statements

This article and any materials distributed in connection with this article may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could” “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the extent to which our internal energy conservation measures and future advancements in renewable energy or low carbon energy technology will enable us to reduce our GHG emissions; the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations, including global health care reforms; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s); and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: https://www.takeda.com/investors/sec-filings/ or at www.sec.gov. Takeda does not undertake to update any of the forward-looking statements contained in this presentation or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this presentation may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.